BlackRock’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9B Sell
212,098,264
-1,287,282
-0.6% -$300M 0.8% 19
2026
Q1
$52.2B Buy
213,385,546
+4,604,387
+2% +$1.07B 0.91% 15
2025
Q4
$43.2B Buy
208,781,159
+1,520,138
+0.7% +$301M 0.73% 15
2025
Q3
$38.4B Buy
207,261,021
+3,411,739
+2% +$585M 0.67% 18
2025
Q2
$31.1B Buy
203,849,282
+4,482,323
+2% +$689M 0.59% 20
2025
Q1
$33.1B Sell
199,366,959
-1,964,640
-1% -$307M 0.69% 18
2024
Q4
$29.1B Buy
201,331,599
+1,379,117
+0.7% +$214M 0.59% 21
2024
Q3
$32.4B Buy
199,952,482
+1,765,658
+0.9% +$281M 0.68% 18
2024
Q2
$29B Buy
198,186,824
+8,460,056
+4% +$1.26B 0.66% 18
2024
Q1
$30B Buy
189,726,768
+3,418,427
+2% +$544M 0.7% 18
2023
Q4
$29.2B Buy
186,308,341
+1,941,109
+1% +$298M 0.74% 16
2023
Q3
$28.7B Sell
184,367,232
-14,975,373
-8% -$2.47B 0.83% 15
2023
Q2
$33B Sell
199,342,605
-2,148,962
-1% -$347M 0.91% 11
2023
Q1
$31.2B Buy
201,491,567
+2,688,798
+1% +$434M 0.92% 11
2022
Q4
$35.1B Sell
198,802,769
-1,089,579
-0.5% -$188M 1.1% 6
2022
Q3
$32.7B Sell
199,892,348
-5,511,759
-3% -$933M 1.11% 8
2022
Q2
$36.5B Buy
205,404,107
+4,604,918
+2% +$820M 1.17% 8
2022
Q1
$35.6B Buy
200,799,189
+777,837
+0.4% +$132M 0.96% 9
2021
Q4
$34.2B Buy
200,021,352
+4,982,885
+3% +$816M 0.87% 10
2021
Q3
$31.5B Buy
195,038,467
+3,653,357
+2% +$623M 0.88% 9
2021
Q2
$31.5B Buy
191,385,110
+1,694,112
+0.9% +$280M 0.88% 9
2021
Q1
$31.2B Buy
189,690,998
+1,180,456
+0.6% +$191M 0.92% 8
2020
Q4
$29.7B Sell
188,510,542
-5,238,237
-3% -$773M 0.95% 8
2020
Q3
$28.8B Buy
193,748,779
+34,735
+0% +$5.14M 1.06% 7
2020
Q2
$27.2B Buy
193,714,044
+1,168,129
+0.6% +$170M 1.09% 7
2020
Q1
$25.2B Sell
192,545,915
-306,573
-0.2% -$43.5M 1.24% 5
2019
Q4
$28.1B Buy
192,852,488
+4,222,375
+2% +$573M 1.08% 6
2019
Q3
$24.4B Buy
188,630,113
+779,122
+0.4% +$103M 1.03% 7
2019
Q2
$26.2B Sell
187,850,991
-1,042,702
-0.6% -$144M 1.12% 5
2019
Q1
$26.4B Buy
188,893,693
+5,990,349
+3% +$802M 1.18% 4
2018
Q4
$23.6B Buy
182,903,344
+3,486,924
+2% +$486M 1.19% 4
2018
Q3
$24.8B Buy
179,416,420
+1,106,155
+0.6% +$147M 1.07% 5
2018
Q2
$21.6B Buy
178,310,265
+2,921,241
+2% +$364M 1% 7
2018
Q1
$22.5B Buy
175,389,024
+7,853,141
+5% +$1.06B 1.07% 6
2017
Q4
$23.4B Sell
167,535,883
-881,435
-0.5% -$123M 1.11% 6
2017
Q3
$21.9B Sell
168,417,318
-5,656,446
-3% -$750M 1.1% 5
2017
Q2
$23B Buy
174,073,764
+4,332,612
+3% +$553M 1.22% 4
2017
Q1
$21.1B Buy
169,741,152
+163,152,235
+2,476% +$19.5B 1.16% 3
2016
Q4
$759M Sell
6,588,917
-613,216
-9% -$70.8M 1.07% 7
2016
Q3
$851M Buy
7,202,133
+99,511
+1% +$12.1M 1.22% 6
2016
Q2
$862M Buy
7,102,622
+631,548
+10% +$71.8M 1.3% 6
2016
Q1
$700M Sell
6,471,074
-1,001,296
-13% -$104M 1.13% 6
2015
Q4
$768M Sell
7,472,370
-1,002,427
-12% -$101M 1.13% 6
2015
Q3
$791M Buy
8,474,797
+161,171
+2% +$15.6M 1.24% 7
2015
Q2
$810M Sell
8,313,626
-245,896
-3% -$24.6M 1.2% 7
2015
Q1
$861M Sell
8,559,522
-180,607
-2% -$18.4M 1.19% 7
2014
Q4
$914M Sell
8,740,129
-360,344
-4% -$38M 1.31% 7
2014
Q3
$970M Buy
9,100,473
+5,037
+0.1% +$522K 1.42% 7
2014
Q2
$952M Sell
9,095,436
-286,515
-3% -$29M 1.42% 7
2014
Q1
$922M Buy
9,381,951
+237,616
+3% +$22M 1.49% 5
2013
Q4
$838M Buy
9,144,335
+1,910,996
+26% +$176M 1.37% 7
2013
Q3
$627M Buy
7,233,339
+294,912
+4% +$26.5M 1.18% 8
2013
Q2
$596M Buy
+6,938,427
New +$589M 1.18% 8

Other funds holding JNJ

BlackRock's JNJ Position: Q2 2026 in Review

BlackRock reduced its Johnson & Johnson (JNJ) stake by 0.6% in Q2 2026, selling an estimated $300M and leaving 212,098,264 shares worth $53.9B. The position accounts for 0.8% of the portfolio, ranked #19.

BlackRock first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 3,609 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BlackRock held 212,098,264 shares of Johnson & Johnson worth $53.9B as of Q2 2026.
  • BlackRock sold 1,287,282 Johnson & Johnson shares in Q2 2026, an estimated $300M.
  • Johnson & Johnson made up 0.8% of BlackRock's portfolio in Q2 2026, its #19 holding.
  • BlackRock first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 3,609 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.